IP Verse

Compound For Use In The Treatment Of Ocular Disorders - EP3811943B1

PatentPatent Analysis

EP3811943

AERIE PHARMACEUTICALS
Application Number
EP20207657A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Jan 20, 2023
Grant Date
Feb 22, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3461484B9

Bibliography

The patent EP3811943B1 was granted to Aerie Pharmaceuticals on Feb 22, 2023 following the initial filing on Mar 14, 2014 under the application number EP20207657A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKNov 22, 2023ADMISSIBLE
ISARPATENT PATENT UND RECHTSANWALTE BARTH HASSA PECKMANN UND PARTNER MBBNov 22, 2023ADMISSIBLE
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBNov 22, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents